Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;15(9):625-36.
doi: 10.1089/omi.2011.0032. Epub 2011 Jul 6.

Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections

Gregory A Poland  1 , Inna G Ovsyannikova, Richard B Kennedy, Iana H Haralambieva, Robert M Jacobson
Affiliations
Review

Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections

Gregory A Poland et al. OMICS. 2011 Sep.

Abstract

In this article we define vaccinomics as the integration of immunogenetics and immunogenomics with systems biology and immune profiling. Vaccinomics is based on the use of cutting edge, high-dimensional (so called "omics") assays and novel bioinformatics approaches to the development of next-generation vaccines and the expansion of our capabilities in individualized medicine. Vaccinomics will allow us to move beyond the empiric "isolate, inactivate, and inject" approach characterizing past vaccine development efforts, and toward a more detailed molecular and systemic understanding of the carefully choreographed series of biological processes involved in developing viral vaccine-induced "immunity." This enhanced understanding will then be applied to overcome the obstacles to the creation of effective vaccines to protect against pathogens, particularly hypervariable viruses, with the greatest current impact on public health. Here we provide an overview of how vaccinomics will inform vaccine science, the development of new vaccines and/or clinically relevant biomarkers or surrogates of protection, vaccine response heterogeneity, and our understanding of immunosenescence.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Vaccinomics approach to new vaccine development. Vaccinomics is the application of multidimensional science to the understanding of biologic and immunologic vaccine response and variability in immune responses. Detailed studies of the mechanisms underlying host responses to pathogens coupled with high dimensional analysis of the epigenetic, genetic, transcriptomic, and proteomic, events that culminate in protective immunity, is used to design rational vaccine approaches. These insights lead to the discovery of new knowledge, which, after replication and validation, is then applied to the development of novel vaccine candidates, and in turn, provides new insights into biological processes that further extend scientific knowledge and discovery.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Allman D. Miller J.P. B cell development and receptor diversity during aging. Curr Opin Immunol. 2005a;17:463–467. - PubMed
    1. Allman D. Miller J.P. The aging of early B-cell precursors. Immunol Rev. 2005b;205:18–29. - PubMed
    1. Amanna I.J. Slifka M.K. Wanted, dead or alive: new viral vaccines. Antiviral Res. 2009;84:119–130. - PMC - PubMed
    1. Amanna I.J. Messaoudi I. Slifka M.K. Protective immunity following vaccination: how is it defined? Hum Vaccin. 2008;4:316–319. - PMC - PubMed
    1. Anders J.F. Jacobson R.M. Poland G.A. Jacobsen S.J. Wollan P.C. Secondary failure rates of measles vaccines: a metaanalysis of published studies. Pediatr Infect Dis J. 1996;15:62–66. - PubMed

Publication types